| Literature DB >> 35888699 |
Yawen Qin1, Chaoqun He1, Haoyu Geng1, Wenqiang Wang1, Peng Yang1, Kangsen Mai1, Fei Song1,2,3.
Abstract
Our previous study demonstrated that based on growth performance and feed utilization, cottonseed meal (CSM) could substitute 20% fishmeal (FM) without adverse effect on golden pompano (Trachinotus ovatus). Muscle deposition was also an important indicator to evaluate the efficiency of alternative protein sources. Therefore, the present study was conducted to explore the changes of physiobiochemical and nutrient metabolism in muscle after FM replaced by CSM. Four isonitrogenous and isolipidic experimental diets (42.5% crude protein, 14.0% crude lipid) were formulated to replace 0% (CSM0 diet), 20% (CSM20 diet), 40% (CSM40 diet), and 60% (CSM60 diet) of FM with CSM. Juvenile fish (24.8 ± 0.02 g) were fed each diet for 6 weeks. The results presented, which, compared with the CSM0 diet, CSM20 and CSM40 diets, had no effect on changing the muscle proximate composition and free essential amino acid (EAA) concentration. For glycolipid metabolism, the CSM20 diet did not change the mRNA expression of hexokinase (hk), glucose transport protein 4 (glut4), glucagon-like peptide 1 receptor (glp-1r), while over 20% replacement impaired glucose metabolism. However, CSM20 and CSM40 diets had no effect on altering lipid metabolism. Mechanistically, compared with the CSM0 diet, the CSM20 diet did not change muscle nutritive metabolism through keeping the activities of the nutrient sensing signaling pathways stable. Higher replacement would break this balance and lead to muscle nutritive metabolism disorders. Based on the results, CSM could substitute 20-40% FM without affecting the muscle nutritive deposition. All data supplemented the powerful support for our previous conclusion that CSM could successfully replace 20% FM based on growth performance.Entities:
Keywords: cottonseed meal; fish nutrition; marine aquaculture; nutrient; physiobiochemical; replacement
Year: 2022 PMID: 35888699 PMCID: PMC9315803 DOI: 10.3390/metabo12070576
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Muscle proximate composition of golden pompano fed diets containing various levels of CSM.
| Diet Groups (% Wet Weight) | |||||
|---|---|---|---|---|---|
| CSM0 | CSM20 | CSM40 | CSM60 | ||
| Moisture | 69.34 ± 0.080 b | 69.47 ± 0.32 ab | 70.24 ± 0.26 ab | 70.51 ± 0.21 a | 0.018 |
| CP | 20.03 ± 0.17 | 20.72 ± 0.51 | 19.84 ± 0.88 | 20.51 ± 0.23 | 0.208 |
| CF | 8.91 ± 0.65 a | 7.21 ± 0.026 ab | 7.21 ± 0.57 ab | 6.83 ± 0.23 b | 0.044 |
| Ash | 1.26 ± 0.027 | 1.33 ± 0.026 | 1.25 ± 0.018 | 1.31 ± 0.058 | 0.407 |
The results were presented as mean ± SEM. Means in the same row with different superscript letters are significantly different (p < 0.05). Note: CP, crude protein; CF, crude fat.
Free amino acid profile in muscle of golden pompano fed different experimental diets.
| Diet Groups (ng/mg) | |||||
|---|---|---|---|---|---|
| CSM0 | CSM20 | CSM40 | CSM60 | ||
| Met | 43.71 ± 0.93 a | 44.84 ± 1.13 ab | 40.89 ± 1.33 ab | 33.22 ± 1.96 b | 0.001 |
| Phe | 43.62 ± 3.19 a | 33.38 ± 1.77 ab | 31.61 ± 0.37 b | 30.93 ± 2.96 b | 0.017 |
| Val | 167.53 ± 10.73 a | 139.53 ± 11.59 ab | 141.54 ± 2.90 ab | 112.07 ± 10.51 b | 0.023 |
| Ile | 127.65 ± 10.40 a | 106.72 ± 7.35 ab | 104.23 ± 1.03 ab | 83.89 ± 7.86 b | 0.022 |
| Leu | 205.13 ± 18.18 | 172.39 ± 12.98 | 166.00 ± 1.41 | 148.16 ± 13.30 | 0.07 |
| Thr | 178.37 ± 6.70 | 148.73 ± 16.26 | 141.79 ± 2.33 | 137.10 ± 8.44 | 0.067 |
| Lys | 319.69 ± 20.04 | 368.12 ± 8.13 | 335.26 ± 27.18 | 309.99 ± 3.01 | 0.174 |
| His | 63.99 ± 1.81 ab | 67.40 ± 1.08 a | 58.14 ± 5.29 ab | 50.96 ± 2.85 b | 0.029 |
| Arg | 62.77 ± 2.20 | 66.22 ± 0.27 | 60.94 ± 5.15 | 62.51 ± 1.96 | 0.655 |
| EAA | 1212.48 ± 40.76 a | 1147.33 ± 58.05 ab | 1080.40 ± 31.39 ab | 968.84 ± 38.64 b | 0.021 |
| Glu | 400.00 ± 38.53 | 405.77 ± 30.42 | 413.25 ± 20.72 | 446.68 ± 7.68 | 0.632 |
| Gly | 1866.44 ± 86.41 a | 1854.01 ± 18.75 a | 1564.49 ± 46.94 ab | 1349.20 ± 119.88 b | 0.004 |
| Pro | 96.91 ± 7.27 a | 81.52 ± 0.47 ab | 76.64 ± 0.59 b | 71.41 ± 3.19 b | 0.01 |
| Ala | 449.77 ± 11.61 | 439.88 ± 2.36 | 429.38 ± 17.31 | 461.63 ± 4.09 | 0.251 |
| Asp | 15.11 ± 0.84 | 16.11 ± 1.04 | 12.72 ± 0.80 | 12.36 ± 0.86 | 0.046 |
| Tyr | 38.81 ± 2.47 a | 29.87 ± 0.98 ab | 29.04 ± 0.12 b | 28.90 ± 2.80 b | 0.021 |
| Ser | 187.81 ± 3.59 | 180.68 ± 5.42 | 177.38 ± 10.78 | 174.06 ± 8.75 | 0.64 |
| Tau | 1738.72 ± 59.66 | 1762.94 ± 46.02 | 1776.66 ± 8.59 | 1550.36 ± 85.14 | 0.072 |
| NEAA | 4793.57 ± 62.88 a | 4771.29 ± 67.07 a | 4479.57 ± 27.84 b | 4094.60 ± 46.06 b | 0 |
| Total AA | 6006.05 ± 93.11 a | 5918.42 ± 80.25 a | 5559.97 ± 24.53 b | 5063.44 ± 74.82 c | 0 |
The results were presented as mean ± SEM. Means in the same row with different superscript letters are significantly different (p < 0.05). Note: Met, methionine; Phe, phenylalanine; Val, valine; Ile, isoleucine; Leu, leucine; Thr, threonine; Lys, lysine; His, histidine; Arg, arginine; EAA, essential amino acids; Glu, glutamine; Gly, glycine; Pro, proline; Ala, alanine; Asp, asparagine; Tyr, tyrosine; Ser, serine; Tau, taurine; NEAA, non-essential amino acids; TAA, total amino acids.
Figure 1Diagrammatic representation of the gene expression pattern of (a) the key enzyme and transporters involved in glucose metabolism and (b) hormone receptors involved in insulin signaling pathway and glp-1r signaling in muscle after golden pompano (Trachinotus ovatus) were fed CSM0, CSM20, CSM40 and CSN60. Data were represented as mean ± SEM. Different letters above the bars denote significant differences between diet groups at the p < 0.05 level. Note: g6pdh, glucose-6-phosphate; hk, hexokinase; pk, pyruvate kinase; pfk-1, phosphofructokinase-1; pepck, phosphoenolpyruvate carboxykinase; glut2, glucose transport protein 2; glut4, glucose transport protein 4; irs1, insulin receptor substrate 1; igf-1r, insulin-like growth factor-1 receptor; glp-1r, glucagon-like peptide 1 receptor.
Figure 2Effects of different experimental diets on the mRNA expression levels of (a) lipid anabolism, (b) lipid catabolism and (c) lipid transporters in muscle after the golden pompano (Trachinotus ovatus) were fed different diets. Data were represented as mean ± SEM. Different letters above the bars denote significant differences between diet groups at the p < 0.05 level. Note: FAS, fatty acid synthetase; ACC, acetyl-CoA carboxylase; AGPAT3, 1-acylglycerol-3-phosphate acyltransferase 3; FAD, fatty acyl desaturase; elovl5, elongase of very long-chain fatty acids 5; SREBP1, sterol regulatory element binding protein-1; PPARα, peroxisome proliferator activated receptors-alpha; PPARγ, peroxisome proliferator-activated receptors gamma; LPL, lipoprotein lipase; HSL, hormone-sensitive lipase; CPT1, carnitine palmitoyl transferase 1; FABP1, fatty acid binding protein 1; APROB100, apolipoprotein b 100.
Figure 3LAT2, SNAT2 and PEPT1 expression in muscle of juvenile golden pompano (Trachinotus ovatus) after fed test diets for 6 weeks. Data were represented as mean ± SEM. Different letters above the bars denote significant differences between diet groups at the p < 0.05 level. Note: LAT2, L-type amino acid transporter 2; SNAT2, sodium-coupled neutral amino acid transporter 2; PEPT1, oligopeptide transporter1.
Figure 4Different diets affected the relative gene expression of the key regulators of GH-IGF-1 axis in muscle of juvenile golden pompano (Trachinotus ovatus). Data were represented as mean ± SEM. Different letters above the bars denote significant differences between diet groups at the p < 0.05 level. Note: GH, growth hormone; IGF-1, insulin-like growth factor-1; IGF-2, insulin-like growth factor-2.
Figure 5The mRNA expression and protein phosphorylation level of key regulators related to target of rapamycin (TOR) and amino acid response (AAR) signaling pathways in muscle. (a) mRNA expression level of TOR signaling pathway; (b) mRNA expression of AAR signaling pathway; (c) protein phosphorylation level of TOR and AAR signaling pathways. Data were represented as mean ± SEM. Different letters above the bars denote significant differences between diet groups at the p < 0.05 level. Note: TOR, target of rapamycin; S6, S6 Ribosomal Protein. 4E-BP1, eukaryotic initiation factor 4E-binding protein 1; eIF2α, initiation elongation factor alpha; ATF4, activating transcription factor 4; CHOP, channelopsin2; REDD1, regulated in development and DNA damage responses 1; AKT, protein kinase B.
Experimental diet formulations.
|
| Diets (% Dry Weight) | |||
|---|---|---|---|---|
| CSM0 | CSM20 | CSM40 | CSM60 | |
| Fishmeal | 25.00 | 20.00 | 15.00 | 10.00 |
| Cottonseed meal (CSM) | 0.00 | 5.00 | 10.00 | 15.00 |
| Corn gluten meal | 13.00 | 13.00 | 13.00 | 13.00 |
| Poultry by-product meal | 11.00 | 11.00 | 11.00 | 11.00 |
| Soybean meal | 8.50 | 8.50 | 8.50 | 8.50 |
| Peanut meal | 6.50 | 6.50 | 6.50 | 6.50 |
| Wheat meal | 17.50 | 17.50 | 17.50 | 17.50 |
| Fish oil | 1.50 | 2.00 | 2.40 | 2.80 |
| Soybean oil | 5.00 | 5.00 | 5.00 | 5.00 |
| Soybean lecithin | 2.50 | 2.50 | 2.50 | 2.50 |
| Monocalcium phosphate | 1.50 | 1.70 | 1.90 | 2.10 |
| Lysine | 0.28 | 0.45 | 0.60 | 0.75 |
| Methionine | 0.10 | 0.15 | 0.20 | 0.25 |
| Threonine | 0.01 | 0.03 | 0.05 | 0.07 |
| Squid paste | 1.50 | 1.50 | 1.50 | 1.50 |
| Mineral premix 1 | 1.50 | 1.50 | 1.50 | 1.50 |
| Vitamin premix 2 | 0.50 | 0.50 | 0.50 | 0.50 |
| Chromium trioxide | 0.10 | 0.10 | 0.10 | 0.10 |
| Lutein | 0.10 | 0.10 | 0.10 | 0.10 |
| Antioxidant | 0.05 | 0.05 | 0.05 | 0.05 |
| Mold inhibitor | 0.10 | 0.10 | 0.10 | 0.10 |
| Cellulose | 3.76 | 2.82 | 2.00 | 1.18 |
|
| ||||
| DM (%) | 90.24 | 89.98 | 89.91 | 90.12 |
| Crude protein (%) | 42.42 | 42.51 | 42.58 | 42.66 |
| Crude lipid (%) | 14.00 | 14.09 | 14.07 | 14.05 |
1 Mineral premix (mg/kg diet): NaF, 2 mg; KI, 0.8 mg; CoCl2·6H2O (10 g/kg), 50 mg; CuSO4·5H2O, 10 mg; FeSO4·H2O, 80 mg; ZnSO4·H2O, 50 mg; MnSO4·H2O, 60 mg; MgSO4.7H2O, 1200 mg; Ca(H2PO4)2·H2O, 3000 mg; NaCl, 100 mg; zeolite, 15,447 mg. 2 Vitamin premix (mg/kg diet): thiamin, 25 mg; riboflavin, 45 mg; pyridoxine HCl, 20 mg; vitamin B12, 0.1 mg; vitamin K3, 10 mg; inositol, 800 mg; pantothenic acid, 60 mg; niacin acid, 200 mg; folic acid, 20 mg; biotin, 1.20 mg; retinal acetate, 32 mg; cholecalciferol, 5 mg; α-to-copherol, 120 mg; ascorbic acid, 2000 mg; choline chloride, 2500 mg; ethoxyquin 150 mg; wheat middling, 14,012 mg.
The essential amino acid composition of the experimental diets.
|
| Diets (% Dry Weight) | |||
|---|---|---|---|---|
| CSM0 | CSM20 | CSM40 | CSM60 | |
| Lys | 1.90 | 1.92 | 1.92 | 1.91 |
| Met | 0.70 | 0.70 | 0.70 | 0.70 |
| Thr | 0.88 | 0.88 | 0.88 | 0.88 |
| Arg | 1.29 | 1.51 | 1.73 | 1.95 |
| His | 0.47 | 0.49 | 0.51 | 0.53 |
| Ile | 0.84 | 0.81 | 0.79 | 0.77 |
| Leu | 1.51 | 1.48 | 1.45 | 1.42 |
| Phe | 0.89 | 0.94 | 0.99 | 1.04 |
| Val | 1.02 | 1.01 | 0.99 | 0.97 |
| Cys | 0.15 | 0.18 | 0.20 | 0.23 |
| Tyr | 0.66 | 0.65 | 0.65 | 0.64 |
Primers used for determining gene expression.
| Target Gene | Forward Sequence (5′–3′) | Reverse Sequence (5′–3′) |
|---|---|---|
| g6pdh | CTGTGGCAAAAGTTGGTGTG | CCTGATGATGTGAGGGATGA |
| hk | CCTTCCTCGTCTTTGTCATTT | TGTCCGTCTCATCCTGGTG |
| pk | TTTGCCAGTTTCATCCGCT | CCATCACGCCATCGCTCT |
| pfk-1 | TGGGTGGGACCGTGATT | AGGTTGGTGATGCCTTTCTT |
| pepck | TGGAGTGTTTGTTGGAGCAG | CGAAGTTGTAGCCGAAGAAG |
| glut2 | TCCTGTTTGCTGTGCTGCTT | GTTTTCCGTCCCTTGCG |
| glut4 | AATGGCTGTGGCTGGCTT | AGGTTTTTCCCCGTGTTTCT |
| irs1 | GCTCCACCCCTCTATTATCTCCT | GTACCTCCCACAGTTCCTCAGTC |
| igf-i r | TTCTGCTGTGCTCTTGTCT | GATGTTTTTGGTGTGGCT |
| glp-1 r | GGCAATCTCTCCTGTTCCC | AGCCTCTGCTTTTATTCGTG |
| FAS | GATGGATACAAAGAGCAAGG | GTGGAGCCGATAAGAAGA |
| ACC | GTTGTCAATCCCAGCCGATC | ATCCACAATGTAGGCCCCAA |
| AGPAT3 | CTTCCTGTTTTGGGCCACTC | GTCGCCATAACTTGAGCCTG |
| FAD | GAACAATCCCACTTCAACG | AGGAATCCCATACTTCTCACA |
| elovl5 | TACATGGTCACGCTCATTATCC | CCGTTCTGATGCTCCTTCTTTA |
| SREBP1 | GAGCCAAGACAGAGGAGTGT | GTCCTCTTGTCTCCCAGCTT |
| PPARα | AATCTCAGCGTGTCGTCTT | GGAAATGCTTCGGATACTTG |
| PPARγ | TCAGGGTTTCACTATGGCGT | CTGGAAGCGACAGTATTGGC |
| LPL | TTTGTCCTTCCTCGTCACCA | AAGACAGCATCCTCTCCACC |
| HSL | TCATACCTCCACACCAACCC | GTCTCGCAGTTTCTTGGCAA |
| CPT1 | CTTTAGCCAAGCCCTTCATC | CACGGTTACCTGTTCCCTCT |
| FABP1 | CCAAGGACATCAAGCCAATTAC | TGGTGATTTCAGCCTCCTTAC |
| APROB100 | AAAAGCCACAAGACGAAAGCA | GAAGCAGCAAAAGGCAGAGC |
| LAT2 | CTCCCAGCAGCTTCTCACCAAAC | CTCGTGCCATCTTCATCTCCATC |
| SNAT2 | CTGCTGGCTGCCCTTTTCGGATA | AGGACAGGTGCTGGTTGATGGAG |
| PEPT1 | AACTGGTCTCCTCCAAACGC | GTTGGAGCCATTCCCACTGT |
| GH | CGGAGCAGTCAGAGTCTTCTACCT | TTCCACAGTAAAACAGTCATCATCAT |
| IGF-1 | CGCAATGGAACAAAGTCGG | AGGAGATACAGCACATCGCACT |
| IGF-2 | GCAAAGACACGGACCCCACT | CGAGGCCATTTCCACAACG |
| TOR | GGGTCTTATGAGCCAGTGCCAGG | CTTCAGGGTTGTCAGCGGATTGT |
| S6 | GCACTGTCCCTCGCCGTCTT | CTGGGCTTCTTGCCTTCTTT |
| 4E-BP1 | ACACCCCAGCAGGAACTTT | GTGACCATCAACGACGCAG |
| eIF2α | TGTATTCCAGCACCTCAGCC | CGTGGTCGTCATCCGAGTAGA |
| ATF4 | CTGCGTCACCCCTCAACTCC | CATTCGCTCCATCCACAACC |
| CHOP | CGGAGTTTCTGGATGTTTTGGA | AGGAGGAGGAAGAGGAGGATGA |
| REDD1 | AGCCAAAGACTCAGAATGCG | TGAAAGGTGGGGACAAGGTA |
| β-actin | TACGAGCTGCCTGACGGACA | GGCTGTGATCTCCTTCTGC |